Commission Regulation (EU) 2017/1016 of 14 June 2017 amending Annexes II, III and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for benzovindiflupyr, chlorantraniliprole, deltamethrin, ethofumesate, haloxyfop, Mild Pepino Mosaic Virus isolate VC1, Mild Pepino Mosaic Virus isolate VX1, oxathiapiprolin, penthiopyrad, pyraclostrobin, spirotetramat, sunflower oil, tolclofos-methyl and trinexapac in or on certain products
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD) Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XII Foodstuffs
Joint committee decision (JCD)
219/2017 In force in the EEA
Yes Legal documents
Commission Regulation (EU) 2017/1016 of 14 June 2017 amending Annexes II, III and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for benzovindiflupyr, chlorantraniliprole, deltamethrin, ethofumesate, haloxyfop, Mild Pepino Mosaic Virus isolate VC1, Mild Pepino Mosaic Virus isolate VX1, oxathiapiprolin, penthiopyrad, pyraclostrobin, spirotetramat, sunflower oil, tolclofos-methyl and trinexapac in or on certain products
Reglugerð framkvæmdastjórnarinnar (ESB) 2017/1016 frá 14. júní 2017 um breytingu á II., III. og IV. viðauka við reglugerð Evrópuþingsins og ráðsins (EB) nr. 396/2005 að því er varðar hámarksgildi leifa fyrir bensóvindíflúpýr, klórantranilípról, deltametrín, etófúmesat, haloxýfóp, vægt pepínómósaíkveirueinangur VC1, vægt pepínómósaíkveirueinangur VX1, oxaþíapíprólín, penþíópýrað, pýraklóstróbín, spírótetramat, sólblómaolíu, tólklófosmetýl og trínexapak í eða á tilteknum afurðum
Verordnung (EU) 2017/1016 der Kommission vom 14. Juni 2017 zur Änderung der Anhänge II, III und IV der Verordnung (EG) Nr. 396/2005 des Europäischen Parlaments und des Rates hinsichtlich der Rückstandshöchstgehalte für Benzovindiflupyr, Chlorantraniliprol, Deltamethrin, Ethofumesat, Haloxyfop, Mildes Pepino Mosaic Virus-Isolat VC1, Mildes Pepino Mosaic Virus-Isolat VX1, Oxathiapiprolin, Penthiopyrad, Pyraclostrobin, Spirotetramat, Sonnenblumenöl, Tolclofos-methyl und Trinexapac in oder auf bestimmten Erzeugnissen
Kommisjonsforordning (EU) 2017/1016 av 14. juni 2017 om endring av vedlegg II, III og IV til europaparlaments- og rådsforordning (EF) nr. 396/2005 med hensyn til grenseverdier for benzovindiflupyr, klorantraniliprol, deltametrin, etofumesat, haloksyfop, mildt pepino-mosaikkvirusisolat VC1, mildt pepino-mosaikkvirusisolat VX1, oksatiapiprolin, pentiopyrad, pyraklostrobin, spirotetramat, solsikkeolje, tolklofosmetyl og trineksapak i eller på visse produkter
History
16.12.2017
Adopted JCD confirmed entry into force date
16.12.2017
Compliance date in the EEA
15.12.2017
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
17.10.2017
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
14.06.2017
Adoption date in the EU
11.07.2017
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.